Product
Double Dose
1 clinical trial
4 indications
Indication
Chronic ConjunctivitisIndication
Stevens-Johnson SyndromeIndication
Toxic Epidermal NecrolysisIndication
pemphigoidClinical trial
Phase IIa Multicenter Clinical Trial to Determine the Feasibility and Safety of the Use of Adipose-derived Mesenchymal Stem Cells (ASC) in the Treatment of Patients With Cicatricial Conjunctivitis Associated With Lyell's Syndrome, Stevens-Johnson Syndrome and Pemphigoid of the Mucous Membranes With Ocular Involvement.Status: Active (not recruiting), Estimated PCD: 2024-02-01